Anxiety and worry are normal responses for children undergoing cancer therapy. For some children, however, anxiety can become so severe that it interferes with their ability to access care and substantially impacts the quality of life of both the patient and their family. This round table will discuss ways of identifying anxiety beyond “normal response” in young children (age 3-9) and discuss pharmacologic and non-pharmacologic methods of improving the symptoms.
Alex Drossos, MD, MBA, MEd, FRCPC,
Child and Youth Mental Health Program,
McMaster Children’s Hospital, Hamilton Health Sciences
Psychiatry and Behavioural Neurosciences,
Michael G. DeGroote School of Medicine, McMaster University
In addition to his interest in pediatric psychosocial oncology, Dr. Alex Drossos is passionate about neurodevelopmental disorders including FASD, school mental health, Indigenous mental health and e-health. His previous work and educational experiences are varied, including computer engineering, health services management, health professional education and Indigenous health. His prior work also includes three years with Cancer Care Ontario in the early 2000s in various positions, including decision support, EMR implementation and surgical oncology program management.